BGI Genomics, Sanguine to Partner on Precision Medicine Trial Database

BGI Genomics and Sanguine BioSciences said they will partner to develop a database combining genomic and clinical data, with the goal of accelerating patient recruitment for precision medicine clinical trials, through a partnership whose value was not disclosed.The companies said their first project will entail a collaboration designed to help clinical trial developers access searchable whole-genome and electronic medical record (EMR) data of more than 1000 patients diagnosed with rheumatoid art